Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Volpi

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Chemotherapy (Florence, Italy)|October 22, 2025
Thrice-weekly teicoplanin: an old drug for modern needs. Experience of its use as outpatient parenteral antibiotic therapy (OPAT) at infectious disease unit of Manzoni hospital (Lecco)Valentina Morena, Federico Conti, Dario Cattaneo, et al.
Antibiotics (Basel, Switzerland)|November 24, 2023
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic InfectionsAltea Gallerani, Milo Gatti, Andrea Bedini, et al.
Journal of Fungi (Basel, Switzerland)|March 27, 2026
Rezafungin as Primary Prophylaxis of <i>Pneumocystis jirovecii</i> Pneumonia in a Critically Ill Person Presenting with AIDS with Trimethoprim/Sulfamethoxazole Allergy: A Case ReportMartina Bottanelli, Alice Mulè, Chiara Molteni, et al.
Clinical Lung Cancer|May 23, 2025
A Propensity-Matched Comparison Between Minimally Invasive Surgery and Stereotactic Radiotherapy in the Treatment of Clinical Stage IA Non-Small-Cell Lung Cancer (NSCLC)Eleni Josephides, Niccolò Daddi, Pietro Bertoglio, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 28, 2020
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediatorCristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, et al.
Jac-Antimicrobial Resistance|December 15, 2021
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant <i>Pseudomonas aeruginosa</i> (DTR-P) infectionsMarianna Meschiari, Sara Volpi, Matteo Faltoni, et al.
BMJ Open|January 4, 2022
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in ItalyMarianna Meschiari, Alessandro Cozzi-Lepri, Roberto Tonelli, et al.
European Journal of Immunology|September 10, 2020
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumoniaSara De Biasi, Domenico Lo Tartaro, Marianna Meschiari, et al.
Communications Biology|December 15, 2022
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patientsClaudia Alteri, Valeria Fox, Rossana Scutari, et al.
Scientific Reports|June 2, 2023
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypesGiovanni Guaraldi, Jovana Milic, Sara Barbieri, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Chemotherapy (Florence, Italy)|October 22, 2025
Thrice-weekly teicoplanin: an old drug for modern needs. Experience of its use as outpatient parenteral antibiotic therapy (OPAT) at infectious disease unit of Manzoni hospital (Lecco)Valentina Morena, Federico Conti, Dario Cattaneo, et al.
Antibiotics (Basel, Switzerland)|November 24, 2023
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic InfectionsAltea Gallerani, Milo Gatti, Andrea Bedini, et al.
Journal of Fungi (Basel, Switzerland)|March 27, 2026
Rezafungin as Primary Prophylaxis of <i>Pneumocystis jirovecii</i> Pneumonia in a Critically Ill Person Presenting with AIDS with Trimethoprim/Sulfamethoxazole Allergy: A Case ReportMartina Bottanelli, Alice Mulè, Chiara Molteni, et al.
Clinical Lung Cancer|May 23, 2025
A Propensity-Matched Comparison Between Minimally Invasive Surgery and Stereotactic Radiotherapy in the Treatment of Clinical Stage IA Non-Small-Cell Lung Cancer (NSCLC)Eleni Josephides, Niccolò Daddi, Pietro Bertoglio, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 28, 2020
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediatorCristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, et al.
Jac-Antimicrobial Resistance|December 15, 2021
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant <i>Pseudomonas aeruginosa</i> (DTR-P) infectionsMarianna Meschiari, Sara Volpi, Matteo Faltoni, et al.
BMJ Open|January 4, 2022
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in ItalyMarianna Meschiari, Alessandro Cozzi-Lepri, Roberto Tonelli, et al.
European Journal of Immunology|September 10, 2020
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumoniaSara De Biasi, Domenico Lo Tartaro, Marianna Meschiari, et al.
Communications Biology|December 15, 2022
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patientsClaudia Alteri, Valeria Fox, Rossana Scutari, et al.
Scientific Reports|June 2, 2023
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypesGiovanni Guaraldi, Jovana Milic, Sara Barbieri, et al.
Pageof 4